| Schedule of error corrections and prior period adjustments |
| Schedule of error corrections and prior period adjustments | |
| | | |
| | | |
| | |
| | |
Previously reported | | |
Adjustment | | |
Revised | |
| Prepayments | |
$ | 193,228 | | |
$ | (130,967 | ) | |
$ | 62,261 | |
| Total Current Assets | |
$ | 234,676 | | |
$ | (130,967 | ) | |
$ | 103,709 | |
| Accounts payable and accrued expenses | |
$ | 16,730 | | |
$ | 19,373 | | |
$ | 36,103 | |
| Total Current Liabilities | |
$ | 645,730 | | |
$ | 19,373 | | |
$ | 665,103 | |
| Additional paid-in capital | |
$ | 1,029,095 | | |
$ | (150,340 | ) | |
$ | 878,755 | |
| Total Stockholders’ Deficit | |
$ | (411,054 | ) | |
$ | (150,340 | ) | |
$ | (561,394 | ) |
The
revisions to the consolidated cash flows for the year ended September 30, 2024 are as follows:
| | |
| | | |
| | | |
| | |
| | |
Previously reported | | |
Adjustment | | |
Revised | |
| Shares issued for services | |
$ | - | | |
$ | 29,686 | | |
$ | 29,686 | |
| Prepayments | |
$ | (18,707 | ) | |
$ | (7,059 | ) | |
$ | (25,766 | ) |
| Accounts payable and accrued expenses | |
$ | (110,431 | ) | |
$ | 119,373 | | |
$ | 8,942 | |
| Net cash used in operating activities | |
$ | (345,288 | ) | |
$ | 142,000 | | |
$ | (203,288 | ) |
| Proceeds from share issuance | |
$ | 242,000 | | |
$ | (142,000 | ) | |
$ | 100,000 | |
| Net cash generated from financing activities | |
$ | 242,000 | | |
$ | (142,000 | ) | |
$ | 100,000 | |
The
revisions to the consolidated cash flows for the three-month ended December 31, 2024 are as follows:
| | |
| | | |
| | | |
| | |
| | |
Previously reported | | |
Adjustment | | |
Revised | |
| Shares issued for services | |
$ | - | | |
$ | 8,813 | | |
$ | 8,813 | |
| Prepayments | |
$ | 38,024 | | |
$ | (8,813 | ) | |
$ | 29,211 | |
|